切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2015, Vol. 01 ›› Issue (01) : 42 -47. doi: 10.3877/cma.j.jssn.2096-1537.2015.01.011

所属专题: 重症医学 文献

专家论坛

急性肾损伤:病理生理与治疗
刘海涛1, 于凯江1,*,*   
  1. 1. 150081 哈尔滨,哈尔滨医科大学
  • 收稿日期:2015-07-08 出版日期:2015-11-28
  • 通信作者: 于凯江
  • 基金资助:
    国家自然科学基金(81571871)

Acute kidney injury: pathophysiology and treatment

Haitao Liu1, Kaijiang Yu1   

  1. 1. Intensive Care Unit, Third Affiliated Hospital of Harbin Medical University, Harbin 150001, China
  • Received:2015-07-08 Published:2015-11-28
  • Corresponding author: Kaijiang Yu
  • About author:
    Corresponding author: Yu Kaijiang, Email: drkaijiang@163.com
引用本文:

刘海涛, 于凯江. 急性肾损伤:病理生理与治疗[J/OL]. 中华重症医学电子杂志, 2015, 01(01): 42-47.

Haitao Liu, Kaijiang Yu. Acute kidney injury: pathophysiology and treatment[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2015, 01(01): 42-47.

急性肾损伤(AKI)是一种常见的临床综合征,主要表现为肾功能快速下降及代谢废物的蓄积,其诊断有赖于血清肌酐的升高和尿量减少。目前尚无治疗AKI的特效药物,严重时需进行肾脏替代治疗,因此早期发现和早期防治成为改善患者预后的关键。为加深对AKI的理解,提高AKI的诊疗水平,本文着重介绍AKI的诊断、病理生理及治疗的相关研究进展。

Acute kidney injury (AKI) is a common clinical syndrome and mainly manifested by the rapid decline of renal function and the accumulation of metabolic waste. The diagnosis of AKI depends on the increase of serum creatinine and/or the decrease of urinary output. Early detection, prevention, and treatment become the key points to improve the prognosis of AKI patients because specific therapies to treat of AKI are still unavailable currently. In order to deepen the understanding of AKI and improve the level of diagnosis and treatment of AKI, this paper focuses on the diagnosis, pathophysiology, and treatment of AKI.

表1 KDIGO的AKI分级诊断标准[4]
图1 AKI的分级管理[4]
[1]
Yang L, Xing GL, Wang L, et al. Acute kidney injury in China: a cross-sectional survey[J]. Lancet, 2015, 386(10002):1465–1471.
[2]
Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group[J]. Crit Care, 2004, 8(4):R204–R212.
[3]
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury[J]. Crit Care, 2007, 11(2):R31.
[4]
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGo clinical practice guideline for acute kidney injury[J]. Kidney Int, 2012, 2(Suppl):1–138.
[5]
Rachoin JS, Daher R, Moussallem C, et al. The fallacy of the BUN: creatinine ratio in critically ill patients[J]. Nephrol Dial Transplant, 2012, 27(6):2248–2254.
[6]
Prowle JR, Molan MP, Hornsey E, et al. Measurement of renal blood flow by phase-contrast magnetic resonance imaging during septic acute kidney injury: a pilot investigation[J]. Crit Care Med, 2012, 40(6):1768–1776.
[7]
Lerolle N, Nochy D, Guérot E, et al. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration[J]. Intensive Care Med, 2010, 36(3):471–478.
[8]
Fenhammar J, Rundgren M, Forestier J, et al. Toll-like receptor 4 inhibitor TAK-242 attenuates acute kidney injury in endotoxemic sheep[J]. Anesthesiology, 2011, 114(5):1130–1137.
[9]
Bellomo R, Wan L, Langenberg C, et al. Septic acute kidney injury: new concepts[J]. Nephron Exp Nephrol, 2008, 109(4):e95–e100.
[10]
Dindyal S, Kyriakides C. Ultrasound microbubble contrast and current clinical applications[J]. Recent Pat Cardiovasc Drug Discov, 2011, 6(1):27–41.
[11]
Xu HX. Contrast-enhanced ultrasound: the evolving applications[J]. World J Radiol, 2009, 1(1):15–24.
[12]
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock[J]. N Engl J Med, 2001, 345(19):1368–1377.
[13]
Uchino S, Doig GS, Bellomo R, et al. Diuretics and mortality in acute renal failure[J]. Crit Care Med, 2004, 32(8):1669–1677.
[14]
Bagshaw SM, Delaney A. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis[J]. Crit Care Resusc, 2007, 9(1):60–68.
[15]
Wang Y, Cui Z, Fan M. Retrospective analysis on Chinese patients diagnosed with acute renal failure hospitalized during the last decade (1994-2003)[J]. Am J Nephrol, 2005, 25(5):514–519.
[16]
Wu VC, Ko WJ, Chang HW, et al. Early renal replacement therapy in patients with postoperative acute liver failure associated with acute renal failure: effect on postoperative outcomes[J]. J Am Coll Surg, 2007, 205(2):266–276.
[17]
Jacka MJ, Ivancinova X, Gibney RT. Continuous renal replacement therapy improves renal recovery from acute renal failure[J]. Can J Anaesth, 2005, 52(3):327–332.
[18]
Rabindranath K, Adams J, Macleod AM, et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults[J]. Cochrane Database Syst Rev, 2007, (3):CD003773.
[19]
De Smedt DM, Elseviers MM, Lins RL, et al. Economic evaluation of different treatment modalities in acute kidney injury[J]. Nephrol Dial Transplant, 2012, 27(11) :4095–4101.
[20]
Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial[J]. Lancet, 2000, 356(9223) :26–30.
[21]
Saudan P, Niederberger M, De Seigneux S, et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure[J]. Kidney Int, 2006, 70(7) :1312–1317.
[22]
Network VNaRFT, Palevsky PM, Zhang JH, et al. Intensity of renal support in critically ill patients with acute kidney injury[J]. N Engl J Med, 2008, 359(1) :7–20.
[23]
Investigators RRTS, Bellomo R, Cass A, et al. Intensity of continuous renal-replacement therapy in critically ill patients[J]. N Engl J Med, 2009, 361(17) :1627–1638.
[24]
Joannes-Boyau O, Honoré PM, Perez P, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial[J]. Intensive Care Med. 2013, 39(9):1535–1546.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 曹琮沅, 黄烁金, 何倩婷, 王安训. 平阳霉素复合剂治疗口腔颌面部脉管畸形的有效性和安全性[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 368-374.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[5] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[6] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[7] 石海波, 赵旭东, 王聪, 曲巍. 气肿性肾盂肾炎、气肿性膀胱炎并脓毒性休克一例报道并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 644-647.
[8] 林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊(第15期)——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[9] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[10] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[11] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 张平骥, 徐钰, 李天水, 庞文翼, 符师宁, 张梦圆. 重症患者镇静治疗现状及期望的调查研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 562-567.
[15] 王昌前, 林婷婷, 宁雨露, 王颖杰, 谭文勇. 光免疫治疗在肿瘤领域的临床应用新进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 575-583.
阅读次数
全文


摘要